[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100344489":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":16,"locations":22,"responsibleParty":42,"collaborators":7,"id":44,"slug":7,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":7,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":7,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Grupo Espanol de Tumores Neuroendocrinos","OTHER",null,[9,13],{"name":10,"affiliation":11,"role":12},"Jorge Hernando Cubero, M.D.","Hospital Universitari Vall d'Hebron, Barcelona","STUDY_DIRECTOR",{"name":14,"affiliation":11,"role":15},"Jaume Capdevila, M.D.","STUDY_CHAIR",[17],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},"Secretaria Técnica GETNE","CONTACT","+34 93 434 44 12","getne@mfar.net",[23],{"facility":24,"status":25,"city":26,"state":7,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Hospital Universitari Vall d'Hebron","RECRUITING","Barcelona","Spain","ES",{"type":30,"coordinates":31},"Point",[32,33],2.15899,41.38879,{"lat":33,"lon":32},[36,39],{"name":37,"role":19,"phone":7,"phoneExt":7,"email":38},"A responsible person designated by the sponsor, M.D.","investigacion@mfar.net",{"name":40,"role":41,"phone":7,"phoneExt":7,"email":7},"Principal investigator selected by the sponsor, M.D.","PRINCIPAL_INVESTIGATOR",{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100344489",false,"NCT03765333","GETNE Registration of Thyroid Cancer","Descriptive Observational Epidemiological Study on the Characteristics of Thyroid Cancer in Patients Treated in Oncology Services of Spanish Centers: National Registry of Thyroid Cancer - Differentiated, Medullary and Anaplastic","Inclusion Criteria:\n\n* Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology.\n* Patients who agree to participate and are able to understand the information sheet and sign the informed consent\n\nExclusion Criteria:\n\n* Patients under 18 years of age.\n* Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed.\n* Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.","ALL","18 Years",{"count":53,"type":54},20,"ESTIMATED","OBSERVATIONAL","An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with diagnosis of primary thyroid cancer.",[58],"Thyroid Cancer","2024-10-02",{"date":61,"type":62},"2024-10-03","ACTUAL",{"date":64,"type":62},"2019-05-28",{"date":66,"type":54},"2025-12",{"name":5,"class":6},1]